<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02693691</url>
  </required_header>
  <id_info>
    <org_study_id>SJM-CIP-10105</org_study_id>
    <nct_id>NCT02693691</nct_id>
  </id_info>
  <brief_title>CardioMEMS European Monitoring Study for Heart Failure</brief_title>
  <acronym>MEMS-HF</acronym>
  <official_title>CardioMEMS European Monitoring Study for Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Medical Devices</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Medical Devices</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to characterize the use of the CardioMEMS™ HF System when used
      in a real-world setting.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Actual">March 1, 2020</completion_date>
  <primary_completion_date type="Actual">March 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>freedom from device/system related complications</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>freedom from pressure sensor failure</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>% successful pulmonary artery pressure data transmissions</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>HF hospitalization rate</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">239</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>CardioMEMS HF System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will collect pulmonary artery pressure measurements daily which will be used by health care professionals to adjust cardiac medications.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CardioMEMS HF System</intervention_name>
    <description>Pulmonary Artery Pressure Monitoring</description>
    <arm_group_label>CardioMEMS HF System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Indicated to receive a CardioMEMS sensor implant per the CardioMEMS™ HF System User's
             Manual

          -  ≥ 18 years of age

          -  Diagnosis of New York Heart Association (NYHA) Class III Heart Failure at the time of
             sensor implantation

          -  Hospitalization for worsening HF, as defined in the protocol, within 12 months prior
             to the CardioMEMS HF System implant

          -  Subjects with reduced Left Ventricular Ejection Fraction (LVEF) must be on stable
             Guideline Directed Medical Therapy (GDMT) as tolerated

          -  Written informed consent obtained from subject

        Exclusion Criteria:

          -  Known coagulation disorders or inability to take two types of blood thinning
             medications for one month after the sensor is implanted

          -  Subjects deemed a candidate for transplant, Ventricular Assist Device, or hospice care
             in the next 12 months or are otherwise not expected to be able to complete the study
             follow up
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christiane Angermann, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Deutsches Zentrum für Herzinsuffizienz Würzburg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Boehm, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Saarland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Klinukum Coburg</name>
      <address>
        <city>Coburg</city>
        <state>Bavaria</state>
        <zip>96450</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Würzburg</name>
      <address>
        <city>Würzburg</city>
        <state>Bavaria</state>
        <zip>97080</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>February 20, 2016</study_first_submitted>
  <study_first_submitted_qc>February 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 29, 2016</study_first_posted>
  <last_update_submitted>April 6, 2020</last_update_submitted>
  <last_update_submitted_qc>April 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>June 19, 2020</submitted>
    <returned>July 8, 2020</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

